DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Hemant Surgical Industries Ltd?

Hemant Surgical Industries Ltd has a price-to-earnings (PE) ratio of 28.1 in the Healthcare sector.

What is the market capitalisation of Hemant Surgical Industries Ltd?

Hemant Surgical Industries Ltd has a market capitalisation of approximately ₹509 crore.

Hemant Surgical Industries Ltd

HEMANTSURGICALINDUSTRIESLTD·NSE·Healthcare

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

Healthcare · Medical Equipment

A steady, established business

52W₹99

₹446-29%

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

₹509 Cr

P/E Ratio

28.10Fair

P/B Ratio

3.06

EPS

₹7.79

Book Value

₹115.00

ROE

18.20%Strong

ROCE

16.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.36Moderate

Face Value

₹10.00

52W High

₹446.00

52W Low

₹99.00

Sector

Healthcare

Industry

Medical Equipment

Fairly Valued

None moatMedium uncertainty

Fair value estimate

₹124

No recent traded price

BearFair valueBull

₹105₹124₹156

/100

Business quality — Solid

Growth 50Profitability 48Efficiency 40Valuation 68

Plain English

Our view

A steady, established business
Low debt relative to equity

Strengths

Low debt relative to equity
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

13% ROE fading to 13% over ~3 yrs, on ₹115 book

₹115

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹156

Analyst target

No analyst coverage

—

Blended fair value₹124

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

28.1Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

18.2%Strong

Above 15% is considered healthy for Indian equities

ROCE

16.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.36Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹509 Cr

P/B

3.06

EPS

₹7.79

Div Yield

—

What changed

Recent changes

Domestic institutions+10.3% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 28.1×

Growth

Strong

+29% rev CAGR

Profitability

Excellent

18.2% ROE

Financial health

Comfortable

D/E 0.36

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+28.6%

+31.0%

10Y

—

Profit

+34.2%

+80.8%

10Y

—

EPS

-1.9%

-33.7%

10Y

—

Profile

Pros

Company has delivered good profit growth of 68.0% CAGR over last 5 years
Company's working capital requirements have reduced from 45.5 days to 24.0 days

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding has decreased over last quarter: -6.07%
Debtor days have increased from 83.7 to 106 days.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 May 2026

Domestic institutions added 10.32 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

53%

Promoter

Promoters

52.8%0.00

Public

22.6%0.00

FII / FPI

0.1%0.00

DII

19.9%+10.32

Others

4.5%

Total shareholders

948

Quarterly trend

Ownership over time

Q1 FY27

Promoter52.83%

FII0.14%

DII19.94%

Public22.61%

Others4.48%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]